Unknown OBSERVATIONAL NCT03622177

Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection

Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection : a Prospective Cross-sectional Observational Study

Sponsor: ANRS, Emerging Infectious Diseases

Conditions HIV I Infection

Interventions biopsie blood drawn

Updated 6 times since 2018 Last updated: Aug 7, 2018 Started: Sep 30, 2018 Primary completion: Sep 30, 2019 Completion: Sep 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on HIV I Infection, this trial is ongoing. The trial is conducted by ANRS, Emerging Infectious Diseases and has accumulated 6 data snapshots since 2018. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Oct 2023 — Jul 2024 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Oct 2021 — Oct 2023 [monthly]

Not Yet Recruiting
Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting

▶ Show 1 earlier version

Sep 2018 — Jan 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ANRS, Emerging Infectious Diseases

Data source: ANRS, Emerging Infectious Diseases

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.